IMFINZI® (durvalumab)-based regimen reduced the risk of death by 22% in early gastric cancer vs. chemotherapy alone in MATTERHORN Phase III trial

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

TEZSPIRE approved in the US for chronic rhinosinusitis with nasal polyps

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
Scientific Research Publishing

Analysis of the Current Status and Influencing Factors of Artificial Intelligence Literacy Ability among Nursing Students ()

Univariate analysis showed that factors such as grade level, family economic status, reasons for choosing nursing major, exposure to AI related courses/training, and daily AI usage time had ...